White Square Capital, a hedge fund that bet GameStop stock would go down in January, has been forced to close down. According to The Financial Times, the London-based hedge fund experienced double-digit percent losses from its attempts to “naked short” the U.S. video game store chain. Simply put, it placed positions that would make money...
Tag: jun 29 2021
Post
CHINA BUSINESS ESPIONAGE NETS $500 BILLION A YEAR
Talk about an imbalance in trade. China’s net from theft of intellectual property and trade secrets from U.S. companies amounts to a half trillion in value a year. That’s according to William Evanina, the recently retired chief of the U.S. National Counterintelligence and Security Center. In 2020, the total U.S. trade deficit with China was...
Post
CHINA SENDS PIC OF DONG
A picture is worth a thousand words…unless it provokes a thousand questions. That’s not exactly a proverb, but it does sum up China’s odd response to rumors that one of its top security officials, Dong Jingwei had defected to the U.S. this past March. The story, based on several unnamed government sources, was first reported...
Post
TRUDEAU MOVES TO REGULATE DIGITAL MEDIA
The Canadian government has, for decades, required TV and radio broadcasters to produce and distribute local content, as a way of preserving Canada’s own culture and limiting the influence of U.S. culture which permeates so much of the media that Canadians consume. That influence is seen as a powerful “cultural invasion…that can steamroll any culture...
Post
FDA & BIG PHARMA, ONE BIG CLUB
The Trends Journal has published several articles recently dealing with the U.S. Food and Drug Administration’s approval of an Alzheimer’s drug, aducanumab, produced by Biogen and sold as Aduhelm, the first new drug for Alzheimer’s disease in almost twenty years. Those articles, such as 15 June’s “ALZHEIMER’S DRUG? FORGET ABOUT IT” and another in this...
Post
FDA APPROVES NON-EVIDENCE BASED DRUG
In our 15 June 2021 article, “ALZHEIMER’S DRUG? FORGET ABOUT IT,” Trends Journal reported on the dissent voiced over the FDA’s approval of Biogen’s new Alzheimer’s drug, the first new Alzheimer’s drug in almost 20 years, aducanumab, to be sold as Aduhelm. The dissent focused on the lack of clinical evidence of the drug’s benefit....
Post
U.S. INTEREST, TRUST IN MEDIA ON THE WANE
The results of a survey on media consumption around the world show that the country where the level of trust between news providers and consumers is lowest is the U.S. RT.com reported on 24 June on the study, Digital News Report 2021, conducted by Oxford University and the Reuters Institute for the Study of Journalism....
Post
VACCINE FAST FACTS
The CDC this past week acknowledged that over 1,200 cases of heart conditions including myocarditis or pericarditis had been reported so far, mostly in people 30, as a result of taking COVID vaccines. That number included over 350 of heart inflammation cases in teens. But despite saying there was a “likely association” between the heart...
Post
COVID “DEATH RATE” TAKES ANOTHER HIT
Another large study is showing that unreported cases of COVID were much more widespread in the U.S. in 2020 than estimated by the CDC. The real world data blows another hole in the narrative concerning the dangers of the virus and the “warp speed” rush to authorize and administer controversial experimental vaccines. According to the...
Post
ESTONIAN LEADER WARNS OF AUTHORITARIAN BENT
Estonia, the smallest of the Baltic States, has, since gaining independence from the Soviet Union in 1991, become a member of the E.U. and NATO and a champion of liberal democracy. So it may come as little surprise that Estonia’s prime minister, Kaja Kallas, knows authoritarianism when she sees it, and is voicing a warning....